SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001621170-15-000002
Filing Date
2015-02-11
Accepted
2015-02-11 14:42:10
Documents
1
Period of Report
2013-06-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2290
  Complete submission text file 0001621170-15-000002.txt   3970
Mailing Address 12655 N. CENTRAL EXPRESSWAY SUITE 1000 DALLAS TX 75243
Business Address 12655 N. CENTRAL EXPRESSWAY SUITE 1000 DALLAS TX 75243 972-386-7350
Endocan Corporation. (Issuer) CIK: 0000054424 (see all company filings)

IRS No.: 900156146 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 4813 Telephone Communications (No Radiotelephone)

Mailing Address TANGLEWOOD, NORTH DEAN HIGH WYCOMBE X0 HP14 4NN
Business Address
Bray DH (Reporting) CIK: 0001621170 (see all company filings)

Type: 3 | Act: 34 | File No.: 002-41703 | Film No.: 15598956